Navigation Links
Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
Date:1/5/2012

g early research on these products, please click on the articles below:

Re: Zertane™ :

Re: Ampion

Re: Optina™

About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation, CNS disease, and male sexual dysfunction. The product pipeline includes new uses for previously approved drugs and new molecular entities ("NMEs"). By concentrating on development of new uses for previously approved drugs, approval timelines, costs and risk of clinical failure are reduced because these drugs have strong potential to be safe and effective while their shorter development times can significantly increase near term value. A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize Ampio's product development programs. For more information about Ampio, please visit our
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
2. Ampio Responds to Recent Publications by Anonymous Short Sellers
3. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
4. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
5. Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™
6. Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
7. Ampio Pharmaceuticals Expands Patent Portfolio of Drugs for Treating Inflammatory Diseases
8. Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation
9. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
10. Ampio Pharmaceuticals Announces a Proof of Concept Trial of Danazol in the Treatment of Allergic Rhinitis Supports Mechanism of Action of Optina™
11. Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
(Date:1/15/2014)... The Cadence Fitness & Health Center has been certified ... Association, a non-profit organization assisting medically integrated health and ... Fitness & Health Center is the only certified fitness ... Chicagoland area. "The certification means the Cadence ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Global Markets ... -- Focus on End Users ... A drug delivery system is ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... the community pharmacy chain, has revealed that one in four* (24%) ... - has taken or applied medicines which they later discovered were ... half (53%) of people do not always check the expiry date ... member. This is worrying considering that nearly one ...
... 4, 2011 Sanofi-aventis (EURONEXT: SAN and NYSE: ... exchange offer for all outstanding shares of common stock of ... and withdrawal rights expired at 11:59 p.m., New York City ... offer has advised sanofi-aventis that, as of the expiration time, ...
Cached Medicine Technology:Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 2Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 3Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation 2Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation 3Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation 4Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation 5Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation 6
(Date:4/17/2014)... PLOS Pathogens , children who live in regions of ... immune response to infection with malaria parasites that may ... and illness and partially control the growth of malaria ... develop future interventions that prevent or mitigate the disease ... 200 million cases of malaria occur worldwide, resulting in ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... synthetic biology team has created a new technology ... that could travel the body and selectively target ... cell-based, biological devices that monitor and modify human ... biology. However, no existing technology enabled bioengineers to ... state and respond in a customized fashion. , ...
(Date:4/17/2014)... as many as 10 million older Americans suffer from ... isolation. , However, new research a project that ... for six years found that Internet use among ... more than 30 percent. , "That,s a very strong ... of telecommunication, information studies and media who led the ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood ... at UC Irvine and the Salk Institute have opened ... prevent stroke-induced brain damage. , A complex and devastating ... and primary reason for disability in the U.S. The ... lets blood-borne material into the brain, causing the permanent ...
Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... ... ... -- R. Shane Jackson, president of LocumTenens.com and executive vice president of Jackson ... member meeting of 2010, which took place on March 25 in Atlanta, Ga. The ...
... longer when they aren,t standing, study finds , WEDNESDAY, April ... new research suggests that patients would be happier if their ... And for doctors, taking a seat doesn,t necessarily have to ... when doctors sat down during a hospital visit, patients ...
... too short or too tall, things are looking up, or ... in The FASEB Journal ( http://www.fasebj.org ) explains ... offers insight into what goes wrong with growth disorders and ... these insights into the mechanisms controlling body growth will help ...
... breath and bested standard test, study found , WEDNESDAY, ... system dubbed the "electronic nose," Italian researchers were able ... diagnostic tools. , The electronic nose detected nearly 90 ... percent who were accurately diagnosed in the traditional way ...
... ... Tahitian Noni Bioactive Beverages , ... Provo, UT (Vocus) April 7, 2010 -- Tahitian Noni International (TNI) announced that ... company has responded. Tahitian Noni International believes that no other product in the industry will ...
... SilverStone ... and 10 at the Peabody Orlando in Orlando, Florida. In addition to hosting a ... also sponsoring the breakout session entitled "Managing Employee Injuries: Caring for Your Employees While ... ...
Cached Medicine News:Health News:R. Shane Jackson Selected as Panelist for Center for Health Transformation Member Meeting 2Health News:R. Shane Jackson Selected as Panelist for Center for Health Transformation Member Meeting 3Health News:Sitting Docs Have Happier Patients 2Health News:Sitting Docs Have Happier Patients 3Health News:Scientists find out why living things are the size they are -- and none other 2Health News:'Electronic Nose' Sniffs Out Asthma 2Health News:'Electronic Nose' Sniffs Out Asthma 3Health News:Not All Fruits Are Superfruits: Not One Network Marketing Superfruit Company Has Accepted Tahitian Noni's Challenge 2Health News:SilverStone Group to Attend Comfort Keepers Annual Conference in Orlando 2
Speculum with malleable plate to support flap during ablation of thestromal bed....
Adjustable wire speculum with 17 mm open blades. Lid tension adjustable throughout procedure with thumb screw control. Available with shaft straight or angled 45 degrees....
Open blade design with aspiration capabilities for removing fluids from the operative site....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Medicine Products: